Диссертация (1151487), страница 24
Текст из файла (страница 24)
Kipper, S.L. Neutrophil-specificTc-labeled anti-CD15 monoclonal99mantibody imaging for diagnosis of equivocal appendicitis / S.L. Kipper, E.B.Rypins, D.G. Evans, et al. // J. Nucl. Med. – 2000. – Vol. 41 (3). – P. 449455.116. Kirschner, A. Radiation dosimetry ofI-19-iodocholesterol: the pitfalls of131using tissue concentration data, the author's reply / A. Kirschner, R. Ice, W.Beierwaltes // J. Nucl. Med. – 1975. – Vol.
16 (3). – P. 248-249.117. Klibanov, A. L. Targeted ultrasound contrast agent for molecular imaging ofinflammation in high-shear flow / A.L. Klibanov, J.J. Rychak, W.C. Yang,et al. // Contrast Media & Mol. Imaging. – 2006. – Vol. 1. – P. 259-266.118. Krasovskii, G.N. Extrapolation of Experimental Data from animals to man /G.N. Krasovskii // Envir. Health Perspect. – 1976. – Vol. 13 (2).
– P. 51-58.148119. Kriegel, H. Biokinetics and metabolism of radio gallium / H. Kriegel // J.Nucl. Med. – 1984. – Vol. 23. – P. 53-57.120. Kumar, V. Potential use of 68Ga-apotransferrin as a PET imaging agent fordetecting Staphylococcus aureus infection / V. Kumar, D.K. Boddeti, S.G.Evans, et al. // Nucl. Med. Biol. – 2011. – Vol. 38.
– P. 393-398.121. Lange, J.M.A. Failure of zidovudine prophylaxis after accidental exposure toHIV-1 / J.M.A. Lange, C.A.B. Boucher, C.E.M. Hollak, et al. // N. Eng. J.Med. – 1990. – Vol. 323. – P. 915-916.122. Lankinen, P.68Ga-DOTAVAP-P1 PET imaging capable of demonstratingthe phase of inflammation in healing bones and the progress ofinfection inosteomyelitic bones / P. Lankinen, T.J. Mäkinen, T.A. Pöyhönen, et al. //Eur. J.
Nucl. Med. Mol. Imaging. – 2008. – Vol. 35. – P. 352-364.123. Larson, S.M. A transferrin-mediated uptake of gallium-67 by EMT-6sarcoma. I. Studies in tissue culture / S.M. Larson, J.S. Rasey, D.R. Allen, etal. // J. Nucl. Med. – 1979. – Vol. 20 (8). – P. 837-842.124.Larson, S.M. Kinetics of binding of carrier-free Ga-67 to humantransferring / S.M.
Larson, D.R. Allen, J.S. Rasey, et al. // J. Nucl. Med. –1978. – Vol. 19 (11). – P. 1245-1249.125. Lavender, J.P. Gallium-67 citrate scanning in neoplastic and inflammatorylesions / J.P. Lavender, J. Lowe, J.R. Barker, et al. // Br. J. Radiol. – 1971. –Vol. 44.
– P. 361-366.126. Laverman, P. A novel method to label liposomes withTc by the99mhydrazine nicotinyl derivative / P. Laverman, E.T.M. Dams, W.J.G. Oyen, etal. // J. Nucl. Med. – 1999. – Vol. 40 (1). – P. 192-197.127. Laverman, P. Development of Infection and Inflammation TargetingCompounds / P. Laverman, C.P. Bleeker-Rovers, F.H.M. Corstens, et al. //Curr. Radiopharm. – 2008. – Vol. 1.
– P. 42-48.128. Levy, B.D. Lipid mediator class switching during acute inflammation:signals in resolution / B.D. Levy, C.B. Clish, B. Schmidt, et al. // Nat.Immunol. – 2001. –Vol. 2. – P. 612-619.149129. Libby, P. Inflammatory mechanisms: the molecular basis of inflammationand disease / P. Libby // Nutrition Rev. – 2007. – Vol. 65 (12). – P. 140-146.130. Lindner, J.R. Noninvasive Ultrasound Imaging of Inflammation UsingMicrobubbles Targeted to Activated Leukocytes / J.R.
Lindner, Ji Song, F.Xu, et al. // Circulation. – 2000. – Vol. 102. – P. 2745-2750.131. Liu, T. Radiolabeled Glucose Derivatives for Tumor Imaging Using SPECTand PET / T. Liu, J. Zhang, X. Wang, et al. // Current Medicinal Chemistry.– 2014. –Vol. 21. – P. 24-34.132. Loevinger, R. MIRD primer for absorbed dose calculations / R. Loevinger,T. Budinger, E. Watson – NY: Society of Nuclear Medicine, 1988.133.
Love, C. Radionuclide Imaging of Infection / C. Love, C.J. Palestro // J.Nucl. Med. Technol. – 2004. – Vol. 32. – P. 47-57.134. Lyra, M. Radiation Dosimetry in infection scintigraphic imaging.Radiopharmaceuticals for inflammations and infections / M. Lyra, A.Frantzis, G. Limouris – Athens: Mediterra Publishers. – 2001. – P. 117-128.135.
Mairal, L. Simultaneous administration of111In-human immunoglobulin andTc-HMPAO labelled leukocytes in inflammatory bowel disease / L.99mMairal, P.D. Lima, C.J. Martin, et al. // Eur. J. Nucl. Med. – 1995. – Vol. 22.– P. 664-670.136. Marcus,C.D.MRimagingofosteomyelitisandneuropathicosteoarthropathy in the feet of diabetics / C.D. Marcus, V.J. Ladam-Marcus,J. Leone, et al. // Radiographics. – 1996. – Vol. 16.
– P. 1337-1348.137. Martinez, J.L. Mechanisms of iron acquisition and bacterial virulence / J.L.Martinez, A. Delgado-Iribarren, F. Baquero // FEMS Microbiol. Rev. –1990. – Vol. 75. – P. 45-56.138. Mc Afee, J.G. Survey of radioactive agents for the in vitro labeling ofphagocytic leucocytes. I Soluble agents. II Particles / J.G. Mc Afee, M.L.Thakur // J. Nucl. Med. – 1976. – Vol. 17 (6). – P.
480-492.150139. Meller, J.18F-FDG PET and PET/CT in Fever of Unknown Origin / J.Meller, C.O. Sahlmann, S.A. Konrad // J. Nucl. Med. – 2007. – Vol. 48 (1).– P. 35-45.140. Merinen, M. Vascular adhesion protein-1 is involved in both acute andchronic inflammation in the mouse / M. Merinen, H. Irjala, M. Salmi, et al. //Am. J. Pathol.
– 2005. – Vol. 166. – P. 793-800.141. Mettler, F.A. Effective doses in radiology and diagnostic nuclear medicine /F.A. Mettler, H. Walter, T.T. Yoshizumi, et al. // Radiology. – 2008. –Vol.248 (1). – P. 254-263.142. Moerlein, S.M. The chemistry of gallium and indium as related toradiopharmaceutical production / S.M. Moerlein, M.J. Welch // Int. J. Nucl.Med. Biol.
– 1981. – Vol. 8. – P. 277-287.143. Moore, E.H. Atypical mycobacterial infection in the lung: CT appearance /E.H. Moore // Radiology. – 1993. – Vol. 187. – P. 777-782.144. Morrel, E.M.Imaging infectionswith antibodies. A quantitativeautoradiographic analysis / E.M. Morrel, R.G. Tompkins, A.J. Fischman, etal. // J. Immunol. Meth. – 1990. – Vol.
130. – P. 39-48.145. Mortelmans, J. Diagnostic role of whole body FDG PET in patients withfever of unknown origin (FUO) / J. Mortelmans, J. De Caestecker, A. Maes,et al. // J. Nucl. Med. – 1990. – Vol. 40 (Suppl. 5). – p. 201.146. Nijhof, M.W. Evaluation of infections of the locomotor system with indium111-labeled human IgG scintigraphy / M.W. Nijhof, W.J.G. Oyen, A. vanKampen, et al. // J. Nucl. Med. 1997. – Vol. 38 (8). – P. 1300-1305.147. O’Reilly, T. Rat model of bacterial osteomyelitis of the tibia.
Handbook ofanimal models of infection / T. O’Reilly, J.T. Mader, O. Zak, et al. – UK:Academic Press. – 1999. – P. 561-575.148. Oster, Z.H. The Effects of Deferoxamine Mesylate on Gallium-67DistributioninNormalandAbscess-BearingAnimals:ConciseCommunication / Z.H. Oster, P. Som, D.F. Sacker, et al. // J. Nucl. Med. –1980. – Vol.
21 (5). – P. 421-425.151149. Oyen, W.J.G. Indium-111-labeled human nonspecific immunoglobulin G: anew radiopharmaceutical for imaging infectious and inflammatory foci /W.J.G. Oyen, R.A. Claessens, J.W.M. van der Meer, et al. // Clin. Infect.Dis. – 1992. – Vol. 14. – P. 1110-1118.150. Palestro, C.J. The current role of gallium imaging in infection / C.J. Palestro// Semin.
Nucl. Med. – 1994. – Vol. 24. – P. 128-141.151. Papos, M. Anti-granulocyte immunoscintigraphy and [99mTc]hexamethylpropyleneamine-oxime-labeled leukocyte scintigraphy in inflammatorybowel disease / M. Papos, F. Nagy, G. Narai, et al. // Dig. Dis.
Sci. – 1996. –Vol. 41. – P. 412-420.152. Peacock, K.Tc-Stannous Colloid White Cell Scintigraphy in Childhood99mInflammatory Bowel Disease / K. Peacock, U. Porn, R. Howman-Giles, etal. // J. Nucl. Med. – 2004. – Vol. 45 (2). – P. 261-265.153. Pellegrino, D. Inflammation and Infection: Imaging properties of18F-FDG-labeled white blood cells versus 18F-FDG / D. Pellegrino, A.A. Bonab, S.C.Dragotakes, et al. // J. Nucl. Med. – 2005. – Vol. 46 (9). – P.
1522-1530.154. Peters,A.M.ClinicalexperiencewithTc-hexamethylpropilene-99mamineoxime for labeling leucocytes and imaging inflammation / A.M.Peters, S. Osman, B.L. Henderson, et al. // Lancet. – 1986. – Vol. 198. – P.946-949.155. Petrik, M.68Ga-Siderophores for PET Imaging of Invasive PulmonaryAspergillosis: Proof of Principle / M. Petrik, H. Haas, C. Decristoforo, et al.// J. Nucl. Med. – 2010. – Vol. 51 (4). – P. 639-645.156. Phelps, M.E. Positron emission tomography provides molecular imaging ofbiological processes / M.E. Phelps // Proc. Natl. Acad. Sci. USA. – 2000. –Vol. 97. – P. 9226-9231.157. Pollak, A.
Imaging inflammation withTc-labelled chemotactic peptides:99manalogues with reduced neutropenia / A. Pollak, A.E. Goodbody, J.R.Ballinger // Nucl. Med. Commun. – 1996. – Vol. 17. – P. 132-135.152158. Puhakka,K.B.Imagingofsacroiliitisinearlyseronegativespondylarthropathy. Assessment of abnormalities by MR in comparison withradiography and CT / K.B. Puhakka, A.G. Jurik, N. Egund, et al. // ActaRadiol. – 2003. – Vol. 44. – P. 218-229.159. Raymond, L.H.
The Medical Use of Gallium Radionuclides: A Brief HistoryWith Some Comments / L.H. Raymond // Semmin. Nucl. Med. – 1978. –Vol. 8. – P. 183-191.160. Rennen, H.J.J. Scintigraphic Imaging of Inflammatory Processes / H.J.J.Rennen, O.C. Boerman, W.J.G. Oyen, et al. // Curr. Med. Chem. – 2002. –Vol. 1. – P. 63-75.161. Rösch, F.68Ge/68Ga Generators: Past, Present and Future / F. Rösch, R.Baum.
– Berlin: Springer. – 2012. – P. 3-16.162. Rubin, R.H. Specific and nonspecific imaging of localized Fisherimmunotype 1 Pseudomonas aeruginosa infection with radiolabeledmonoclonal antibody / R.H. Rubin, L.S. Young, W.P. Hansen, et al. // J.Nucl. Med. – 1988. – Vol. 29 (5). – P. 651-656.163. Segarra, I. Granulocyte-specific monoclonal antibody technetium-99m-BW250/183andindium-111-oxine-labelledleukocytescintigraphyininflammatory bowel disease / I. Segarra, M. Roca, L. Baliellas, et al. // Eur.J. Nucl. Med.
– 1991. – Vol. 18. – P. 715-719.164. Sephton, R.G. Ga-67 and Fe-59 Distributions in Mice / R.G. Sephton, G.S.Hodgson, S. De Abrew, et al. // J. Nucl. Med. – 1978. – Vol. 19 (8). – P.930-935.165. Sonmezoglu, K. Usefulness ofTc-ciprofloxacin (Infection) scan in99mdiagnosis of chronic orthopedic infections: comparative study withTc-99mHMPAO leukocyte scintigraphy / K. Sonmezoglu, M. Sonmezoglu, M.Halac, et al.
// J. Nucl. Med. – 2001. – Vol. 42 (4). – P. 567-574.166. Staab, E.V. Role of Gallium-67 in inflammatory disease / E.V. Staab, W.H.McCartney // Semin. Nucl. Med. – 1978. – Vol. 8. – P. 219-234.153167. Stabin, M. G. Radiation Dose Estimates for Radiopharmaceuticals / M.G.Stabin, J.B. Stubbs, R.E.
Toohey– Oak Ridge: Institute for Science andEducation. Division of Industrial and Medical Nuclear Safety. – 1996. – 98p.168. Stabin, M.G. Physical Models and Dose Factors for Use in Internal DoseAssessment / M.G. Stabin, J.A. Siegel // Health Phys. – 2003. – Vol. 85 (3).– p. 294.169. Stabin, M.G. State of the Art in Nuclear Medicine Dose Assessment / M.G.Stabin // Seminars in Nucl. Med. – 2008.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
